Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -31.510% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1ccn2c(CN3CCOCC3)c(-c3ccccc3)nc2c1
b. CN1CCc2c(sc(NC(=O)c3ccc(S(=O)(=O)N4CCOCC4)cc3)c2C(N)=O)C1
c. Cc1ccc(NC(=O)CSc2nnc(CN3CCOCC3)n2C)cc1C
Answer: a. Cc1ccn2c(CN3CCOCC3)c(-c3ccccc3)nc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccn2c(CN3CCOCC3)c(-c3ccccc3)nc2c1
Cc1ccn2c(CN3CCOCC3)c(-c3ccccc3)nc2c1
4-[(7-methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine